Flinn, Ryan

Ryan Flinn

BioMarin Gains Ahead of Cancer Meeting: San Francisco Mover

May 22, 2013

May 22, 2013

BioMarin Gains Ahead of Cancer Meeting: San Francisco Mover

May 9, 2013

May 9, 2013

Dendreon Falls as Provenge Sales Miss Analysts’ Estimates

May 3, 2013

May 3, 2013

Gilead Rises To Highest Price on Potential Drug Sales

May 3, 2013

May 3, 2013

Health Management Says U.S. Issued Subpoena on Payments

May 2, 2013

May 2, 2013

Arena Withdrawing Obesity Drug Regulatory Application in Europe

May 2, 2013

May 2, 2013

Gilead Misses Analysts’ Profit Estimates on Sales of HIV Drugs

May 2, 2013

May 2, 2013

Gilead’s Hepatitis C Treatment Clears Virus in Eight Weeks

May 2, 2013

May 2, 2013

Medicaid Expansion May Not Improve Health of Poor in U.S.

May 1, 2013

May 1, 2013

Actavis Seen Deserving Second-Best Valuation in Sale: Real M&A

April 27, 2013

April 27, 2013

Valeant Said to Be in Talks With Actavis on Merger

April 25, 2013

April 25, 2013

Ancient Mayan Culture Created From Many Influences, Study Finds

April 24, 2013

April 24, 2013

Amgen Falls After Revenue Growth Misses Estimates

April 22, 2013

April 22, 2013

Chili Peppers Seen Helping 36 Million Migraine Sufferers: Health

April 16, 2013

April 16, 2013

Allergan’s Migraine Drug Inhaler Levadex Rejected

April 4, 2013

April 4, 2013

Dementia Care at $109 Billion Beats Heart Disease on Cost

March 28, 2013

March 28, 2013

Gilead at Record High on Sales Estimate: San Francisco Mover

March 20, 2013

March 20, 2013

Arena Joins Vivus Finding Obesity Drugs Fizzle on Costs: Health

March 19, 2013

March 19, 2013

Affymax Falls After Firing 75% of Workers

March 19, 2013

March 19, 2013

NPS Buys Back Rights to Gattex From Takeda to Spur Sales

March 13, 2013

March 13, 2013

Mars Rover Finds Conditions Once May Have Supported Life